Image usage restrictions: News organizations may use or redistribute this image, with proper attribution, as part of news coverage of this paper only.
TEL AVIV, Israel and WALTHAM, Mass., Nov. 5, 2024 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a commercial stage biopharmaceutical company pursuing life-changing therapies in oncology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results